Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Prophylactic HFNC and pulmonary morbidity: attention to detail

Prophylactic HFNC and pulmonary morbidity: attention to detail Journal of Anesthesia https://doi.org/10.1007/s00540-023-03203-6 LE T TER TO  THE   EDITOR Rohan Magoon Received: 16 April 2023 / Accepted: 8 May 2023 © The Author(s) under exclusive licence to Japanese Society of Anesthesiologists 2023 Keywords Congenital heart disease · High-flow nasal cannula · Pulmonary morbidity · Transfusion To the Editor: or modified ultrafiltration practices were employed across Shimizu et al. are congratulated for their recent single- the patients included in the present study. arm interventional study investigating Postoperative Pulmo- Even in strict relation to evaluating the preventive poten- nary Complications (PPC) after pediatric cardiac surgery tial of HFNC therapy, there are other points in the Shimizu with a specific focus on the efficacy of prophylactic High- et al. study which are worth discussing. Ahead of the sample Flow Nasal Cannula (HFNC) in ameliorating the former [1]. size in a study focusing PPC being premised on the pre- Unable to discover a preventive effect of HFNC in the mat- specified reintubation rates, the inclusion of a heterogene- ter, the authors adequately discuss the concerns regarding ous surgical cohort (with varying pre-existing congenital the predetermined 10% PPC incidence threshold employed cardiac lesions) deserves simultaneous attention [1]. Habre in the study [1]. Nonetheless, additional facets in the cor- http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Anesthesia Springer Journals

Prophylactic HFNC and pulmonary morbidity: attention to detail

Magoon, Rohan
Journal of Anesthesia , Volume 37 (4) – Aug 1, 2023
Download PDF
2 pages

Loading next page...
 
/lp/springer-journals/prophylactic-hfnc-and-pulmonary-morbidity-attention-to-detail-GLfL0lTz0w

References (9)

Publisher
Springer Journals
Copyright
Copyright © The Author(s) under exclusive licence to Japanese Society of Anesthesiologists 2023
ISSN
0913-8668
eISSN
1438-8359
DOI
10.1007/s00540-023-03203-6
Publisher site
See Article on Publisher Site

Abstract

Journal of Anesthesia https://doi.org/10.1007/s00540-023-03203-6 LE T TER TO  THE   EDITOR Rohan Magoon Received: 16 April 2023 / Accepted: 8 May 2023 © The Author(s) under exclusive licence to Japanese Society of Anesthesiologists 2023 Keywords Congenital heart disease · High-flow nasal cannula · Pulmonary morbidity · Transfusion To the Editor: or modified ultrafiltration practices were employed across Shimizu et al. are congratulated for their recent single- the patients included in the present study. arm interventional study investigating Postoperative Pulmo- Even in strict relation to evaluating the preventive poten- nary Complications (PPC) after pediatric cardiac surgery tial of HFNC therapy, there are other points in the Shimizu with a specific focus on the efficacy of prophylactic High- et al. study which are worth discussing. Ahead of the sample Flow Nasal Cannula (HFNC) in ameliorating the former [1]. size in a study focusing PPC being premised on the pre- Unable to discover a preventive effect of HFNC in the mat- specified reintubation rates, the inclusion of a heterogene- ter, the authors adequately discuss the concerns regarding ous surgical cohort (with varying pre-existing congenital the predetermined 10% PPC incidence threshold employed cardiac lesions) deserves simultaneous attention [1]. Habre in the study [1]. Nonetheless, additional facets in the cor-

Journal

Journal of Anesthesia – Springer Journals

Published: Aug 1, 2023

Keywords: Congenital heart disease; High-flow nasal cannula; Pulmonary morbidity; Transfusion

There are no references for this article.